OncoPharm
John Bossaer
Add to My Podcasts
Episodes
About
Reviews
Promote
IRIS
15 minutes
Posted Feb 14, 2019 at 8:47 pm.
0:00
15:50
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
The Landmarks in Oncology Pharmacy series returns to discuss the International Randomized Study of Interferon vs. STI571 (imatinib) aka IRIS.
Previous
Cannabidiol (CBD) & Potential Drug Interactions In Cancer Patients
Next
Axitinib's Big Weekend
← See all 273 episodes of OncoPharm